Business Context and Reporting Period
Company: Community Health Systems, Inc. (CYH)
Filing Type: Form 8-K (Current Report)
Report Date: December 2, 2025
Event Date: December 1, 2025
Context: The Company reported the completion of a significant asset disposition involving its ambulatory outreach business.
Key Financial Metrics
- Transaction Proceeds: Approximately $194 million in cash (before transaction expenses).
- Assets Disposed: Select assets and assumed leases of the ambulatory outreach business across 13 states, including patient service centers and in-office phlebotomy locations.
- Counterparty: Laboratory Corporation of America Holdings.
- Other Metrics: The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity for the reporting period. Pro forma financial information is referenced in Exhibit 99.1 but not detailed in the text.
Material Changes
The primary material change is the divestiture of the ambulatory outreach business. This transaction constitutes a "significant disposition" under Item 2.01 of Form 8-K. The Company has exited this specific segment of operations in 13 states, transferring assets and leases to the Purchaser.
Guidance, Outlook, and Risks
- Management Commentary: The Company issued a press release on December 2, 2025, announcing the completion of the transaction (filed as Exhibit 99.2).
- Pro Forma Information: Unaudited pro forma condensed consolidated financial statements are included as Exhibit 99.1, covering the nine months ended September 30, 2025, and the year ended December 31, 2024.
- Risks and Contingencies: The filing includes standard disclaimers regarding the Purchase Agreement, noting that representations and warranties were made solely for the benefit of the parties and may differ from an investor's view of materiality. No specific new risks or contingencies are detailed in the text beyond the transaction completion.
Investor Verification Checklist
- Review Exhibit 99.1 for the impact of the $194 million cash inflow on the Company's pro forma balance sheet and income statement.
- Verify the specific transaction expenses deducted from the gross purchase price to determine net proceeds.
- Examine the press release (Exhibit 99.2) for any strategic rationale or future operational changes resulting from the divestiture.
- Confirm the status of the 13 states affected and the specific patient service centers included in the sale.